VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 410 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $3,641,000 | -72.2% | 35,822 | -51.1% | 1.69% | -72.8% |
| Q3 2015 | $13,078,000 | +63.2% | 73,316 | +103.2% | 6.21% | +123.2% |
| Q2 2015 | $8,014,000 | +3.3% | 36,073 | -7.7% | 2.78% | +9.6% |
| Q1 2015 | $7,761,000 | +79.0% | 39,076 | +13.7% | 2.54% | +69.1% |
| Q2 2014 | $4,336,000 | -59.7% | 34,382 | -57.8% | 1.50% | -69.0% |
| Q1 2014 | $10,751,000 | -28.5% | 81,550 | -36.3% | 4.85% | -31.8% |
| Q4 2013 | $15,038,000 | +33.6% | 128,088 | +18.7% | 7.11% | +18.1% |
| Q3 2013 | $11,259,000 | +33.8% | 107,917 | +10.4% | 6.02% | +17.9% |
| Q2 2013 | $8,413,000 | – | 97,737 | – | 5.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |